Nano Labs (CTLE) Appoints Mr. Stephan Licari as Director of Global
DETROIT, MI -- (Marketwire) -- 12/04/12 -- Nano Labs Corp. (OTCQB:
CTLE) is pleased to announce today the appointment of Mr. Stephan
Licari as Director of Global Business Opportunities.
Mr. Licari has over 20 years of experience in international
marketing, sales and business development. He has held various
management positions with global companies such as AT&T Canada, Tyco
Healthcare, Valleylab, Arton Capital and Monster Worldwide in the
markets of North America, Europe, the Middle East and Africa (EMEA).
"Stephan brings a wealth of international development knowledge to
the table. He has a strong track record in helping companies grow and
transform their businesses by integrating new technologies," said Mr.
Bernardo Camacho Chavarria, President of Nano Labs. "He will be a
great asset to the team here at Nano Labs, and I look forward to
working closely with him as we explore markets here in North America
Mr. Licari will be responsible for driving the sales team and growth
of Nano Labs by introducing its cutting edge nano technologies to the
global marketplace. He has built and organized teams to generate new
revenue on three different continents.
"I look forward to taking hold of the immense growth opportunities
presented through Nano Labs' IP treasure chest, and to working
closely with senior management and the Board of Directors. My
immediate goals are to address and manage the growing list of
strategic relationships and alliances the company currently is
developing. We are looking to leverage our intellectual property and
marry the work with the proper expertise and channels to bring our
new products to market," stated Mr. Licari.
Mr. Licari's business-development activities will focus on
cultivating relationships with companies, organizations and
governments to work with the Company on strategic, commercial, and
Nano Labs defines the three programs as follows:
> Strategic Partnerships focus on promoting partnerships with
academic and government entities to further the commercial
development of nanotechnology.
> Commercial Partnerships focus on the industrial commercialization
of our products and the licensing o
f a diverse range of our in-house,
intellectual property assets to create new products for mass
> Joint Ventures focus on cooperative financial investments to
commercialize new products and channels.
"On behalf of the Company, I cordially invite all interested parties
to explore the unique capabilities of Nano Labs and the potential of
nanotechnology. Our innovative products and services are available
for licensing by category and/or by territory, and we are looking for
long-term relationships with key licensing and distribution partners.
This may include assigning patents, licensing patents for a field of
use, technology transfer, copyrights, royalty agreements, buying a
product line, and other methods. As well, we design our partner
programs to include milestones and performance-based metrics to
maximize the value of these programs for our partners and our
shareholders," Mr. Licari said.
Mr. Licari holds a Bachelor of Business Administration in Marketing
and International Management from the Ecole des Hautes Etudes
Commerciales (HEC) in Montreal, Quebec.
About Nano Labs
Nano Labs Corp. (CTLE) is a nanotechnology research
and development company which began during October 2012, but is able
to access resources that encompass nearly 30 years of research and
development in nanotechnology as well as hundreds of peer-reviewed
and published research papers and other scholarly material.
The Company's research and development team of scientists, designers,
and engineers is focused on creating a portfolio of advanced products
that could provide benefits to a variety of industries including: (i)
consumer products, (ii) energy, (iii) materials, and (iv) healthcare.
Through the use and integration of proprietary nano compounds, our
goal is to evolve common products into new, revolutionary products in
order to make the world a better place.
Nano Labs shares are traded on the OTC Bulletin Board in the United
States under the ticker CTLE.
For more information, please visit www.NanoLabs.us.
Forward looking statements
This press release contains
forward-looking information within the meaning of the Private
Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1993 and Section 21E of the Securities Exchange Act
of 1934 and is subject to the safe harbor created by those laws.
These forward-looking statements are based upon a number of
assumptions and estimates that are subject to significant
uncertainties that involve known and unknown risks, many of which are
beyond our control and are not guarantees of future performance.
Actual outcomes and results could materially differ from what is
expressed, implied, or forecasted in any such forward-looking
statements and any such difference may be caused by risk factors
listed from time to time in the Company's news releases and/or its
filings with the OTC Bulletin Board or as a result of other factors.
Contact Nano Labs Corp.
Bernardo Camacho Chavarria
1 (888) 806-2315
Press spacebar to pause and continue. Press esc to stop.